Stay updated on ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T20:41:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study record is not accessible. The usual study content and navigation are replaced by an error screen and site footer.
    Difference
    17%
    Check dated 2026-09-19T22:10:08.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing Revision: v3.6.5. This is a minor build/update to the site interface and does not affect the trial information or user actions.
    Difference
    0.1%
    Check dated 2026-08-29T20:59:41.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now displayed on the page, replacing the previous v3.6.4. This indicates a site version update that does not modify the study content or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-08-08T19:17:22.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The website version was updated from v3.6.3 to v3.6.4, representing a maintenance/patch release. This change does not modify the study content or data shown on the page.
    Difference
    0.1%
    Check dated 2026-07-25T11:52:36.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating an underlying platform version bump. This appears to be a software update behind the scenes rather than a change to the study page content.
    Difference
    0.1%
    Check dated 2026-07-03T23:51:58.000Z thumbnail image

Stay in the know with updates to ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.